Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Radiation Injuries × Adrenal Cortex Hormones × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Radiation Injuries 1 Prostatic Neoplasms 1 Popliteal Cyst 1 Pneumonia 1 Optic Neuritis 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Glioma 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Radiotherapy 5 Carboplatin 3 Paclitaxel 2 Donepezil 2 Cisplatin 2 sargramostim 1 cevimeline 1 beta Carotene 1 alpha-Tocopherol 1 Zinc Sulfate 1 Vortioxetine 1 Vitamin E 1 Standard of Care 1 Sodium Chloride 1 Salts 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Oxygen 1 Oxaliplatin 1 Meditation 1 Hyperbaric Oxygenation 1 Glutamine 1 G(M1) Ganglioside 1 Filgrastim 1 Etoposide 1 Erythropoietin 1 Epoetin Alfa 1 Dexamethasone 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06888817 2026-02-25

BRAINS

The Netherlands Cancer Institute

Phase 3 Recruiting

Brain Neoplasms, Glioma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡